SM
BIS icon

Southport Management’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Southport Management’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-375
Closed -$267K – 39
2014
Q1 		$267K Buy
+375
New +$250K 0.29% 33

Other funds holding BIS

HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return
ST
Spot Trading Chicago, Illinois $5.81B AUM 22.41% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Southport Management's BIS Position: Q2 2014 in Review

Southport Management sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q2 2014, closing a stake of 375 shares — an estimated $267K sold.

Southport Management first reported a position in BIS in Q1 2014 and held it in 1 quarter. The position peaked at $267K in Q1 2014. 9 funds tracked by Wall St. Rank hold BIS as of Q2 2014.

  • Southport Management reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q2 2014 after selling out during the quarter.
  • Southport Management sold 375 ProShares UltraShort NASDAQ Biotechnology shares in Q2 2014, an estimated $267K.
  • Southport Management first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q1 2014 and held it in 1 quarter.
  • Southport Management's ProShares UltraShort NASDAQ Biotechnology position peaked at $267K in Q1 2014.
  • 9 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q2 2014.

Based on Southport Management's 13F filing for Q2 2014, filed 14 Aug 2014.